Search by Drug Name or NDC

    NDC 00006-3076-02 PREVYMIS 480 mg/1 Details

    PREVYMIS 480 mg/1

    PREVYMIS is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is LETERMOVIR.

    Product Information

    NDC 00006-3076
    Product ID 0006-3076_21e739f3-f406-4bfe-8363-b8ee526a0a5e
    Associated GPIs 12200045000340
    GCN Sequence Number 077899
    GCN Sequence Number Description letermovir TABLET 480 MG ORAL
    HIC3 W5A
    HIC3 Description ANTIVIRALS, GENERAL
    GCN 44061
    HICL Sequence Number 044622
    HICL Sequence Number Description LETERMOVIR
    Brand/Generic Brand
    Proprietary Name PREVYMIS
    Proprietary Name Suffix n/a
    Non-Proprietary Name LETERMOVIR
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 480
    Active Ingredient Units mg/1
    Substance Name LETERMOVIR
    Labeler Name Merck Sharp & Dohme LLC
    Pharmaceutical Class Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytomegalovirus DNA Terminase Complex Inhibitor [EPC], DNA Terminase Complex Inhibitors [MoA], Organic Anio
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA209939
    Listing Certified Through 2024-12-31

    Package

    NDC 00006-3076-02 (00006307602)

    NDC Package Code 0006-3076-02
    Billing NDC 00006307602
    Package 4 DOSE PACK in 1 CARTON (0006-3076-02) / 7 TABLET, FILM COATED in 1 DOSE PACK (0006-3076-01)
    Marketing Start Date 2017-11-08
    NDC Exclude Flag N
    Pricing Information N/A